# Oral Administration of DCI to Women With PCOS

> **NCT00497653** · PHASE2,PHASE3 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 13 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** DCI
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00497653
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-02
- **Primary completion:** 2007-07
- **Final completion:** 2009-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2011-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497653, "Oral Administration of DCI to Women With PCOS". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00497653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*